APPLICATION
ANDA065085
TYPE
ANDA
ORIGINAL APPROVAL
2003-11-07
LATEST ACTION
2021-07-16
ROUTE
TOPICAL
DOSAGE FORM
OINTMENT
MARKETING STATUS
Prescription
Products
MUPIROCINPrescription
MUPIROCIN 2% · OINTMENT · TOPICAL
Approval history
2021-07-16Labeling · Supplement 11 · standardAP
2021-07-16Labeling · Supplement 12 · standardAP
2015-12-28Labeling · Supplement 10 · standardAP
2015-12-28Labeling · Supplement 9 · standardAP
2004-02-26Labeling · Supplement 1AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.